Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 130


Hiv-2 molecular epidemiology.

Visseaux B, Damond F, Matheron S, Descamps D, Charpentier C.

Infect Genet Evol. 2016 Aug 12. pii: S1567-1348(16)30347-1. doi: 10.1016/j.meegid.2016.08.010.


Evidence of Sexual Transmission of Zika Virus.

D'Ortenzio E, Matheron S, Yazdanpanah Y, de Lamballerie X, Hubert B, Piorkowski G, Maquart M, Descamps D, Damond F, Leparc-Goffart I.

N Engl J Med. 2016 Jun 2;374(22):2195-8. doi: 10.1056/NEJMc1604449. No abstract available.


Women infected with human immunodeficiency virus type 1 have poorer assisted reproduction outcomes: a case-control study.

Stora C, Epelboin S, Devouche E, Matheron S, Epelboin L, Yazbeck C, Damond F, Longuet P, Dzineku F, Rajguru M, Delaroche L, Mandelbrot L, Luton D, Patrat C.

Fertil Steril. 2016 May;105(5):1193-201. doi: 10.1016/j.fertnstert.2015.12.138.


Neurocognition and quality of life after reinitiating antiretroviral therapy in children randomized to planned treatment interruption.

Ananworanich J, Melvin D, Amador JT, Childs T, Medin G, Boscolo V, Compagnucci A, Kanjanavanit S, Montero S, Gibb DM; PENTA 11 Study Group..

AIDS. 2016 Apr 24;30(7):1075-81. doi: 10.1097/QAD.0000000000001011.


Tropism distribution among antiretroviral-naive HIV-2-infected patients.

Visseaux B, Charpentier C, Ozanne A, Nizard A, Drumard S, Fagard C, Glohi D, Damond F, Brun-Vézinet F, Matheron S, Descamps D; ANRS CO5 HIV-2 Cohort..

AIDS. 2015 Oct 23;29(16):2209-12. doi: 10.1097/QAD.0000000000000825.


Response to Hønge et al.: Comment on Gautheret-Dejean et al.: Performance of rapid tests for discrimination between HIV-1 and/or HIV-2 infections.

Gautheret-Dejean A, Bocobza J, Brunet S, Damond F, Plantier JC, Barin F.

J Med Virol. 2016 Mar;88(3):369-70. doi: 10.1002/jmv.24390. No abstract available.


HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds.

Harrison L, Melvin A, Fiscus S, Saidi Y, Nastouli E, Harper L, Compagnucci A, Babiker A, McKinney R, Gibb D, Tudor-Williams G; PENPACT-1 (PENTA 9PACTG 390) Study Team..

J Acquir Immune Defic Syndr. 2015 Sep 1;70(1):42-53. doi: 10.1097/QAI.0000000000000671.


Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates.

Visseaux B, Charpentier C, Collin G, Bertine M, Peytavin G, Damond F, Matheron S, Lefebvre E, Brun-Vézinet F, Descamps D; ANRS CO5 HIV-2 Cohort..

PLoS One. 2015 Aug 6;10(8):e0134904. doi: 10.1371/journal.pone.0134904.


The Two-Phase Emergence of Non Pandemic HIV-1 Group O in Cameroon.

Leoz M, Feyertag F, Kfutwah A, Mauclère P, Lachenal G, Damond F, De Oliveira F, Lemée V, Simon F, Robertson DL, Plantier JC.

PLoS Pathog. 2015 Aug 4;11(8):e1005029. doi: 10.1371/journal.ppat.1005029.


Diphtheria, tetanus, poliomyelitis, yellow fever and hepatitis B seroprevalence among HIV1-infected migrants. Results from the ANRS VIHVO vaccine sub-study.

Mullaert J, Abgrall S, Lele N, Batteux F, Slama LB, Meritet JF, Lebon P, Bouchaud O, Grabar S, Launay O; ANRS VIHVO Study Group..

Vaccine. 2015 Sep 11;33(38):4938-44. doi: 10.1016/j.vaccine.2015.07.036.


Plasma HIV-2 RNA According to CD4 Count Strata among HIV-2-Infected Adults in the IeDEA West Africa Collaboration.

Ekouévi DK, Avettand-Fènoël V, Tchounga BK, Coffie PA, Sawadogo A, Minta D, Minga A, Eholie SP, Plantier JC, Damond F, Dabis F, Rouzioux C; IeDEA West Africa collaboration..

PLoS One. 2015 Jun 25;10(6):e0129886. doi: 10.1371/journal.pone.0129886.


Performance of rapid tests for discrimination between HIV-1 and/or HIV-2 infections.

Gautheret-Dejean A, Bocobza J, Brunet S, Damond F, Plantier JC, Barin F.

J Med Virol. 2015 Dec;87(12):2061-6. doi: 10.1002/jmv.24282.


High level of APOBEC3F/3G editing in HIV-2 DNA vif and pol sequences from antiretroviral-naive patients.

Bertine M, Charpentier C, Visseaux B, Storto A, Collin G, Larrouy L, Damond F, Matheron S, Brun-Vézinet F, Descamps D; ANRS CO5 HIV-2 Cohort..

AIDS. 2015 Apr 24;29(7):779-84. doi: 10.1097/QAD.0000000000000607.


In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.

Sibiude J, Le Chenadec J, Bonnet D, Tubiana R, Faye A, Dollfus C, Mandelbrot L, Delmas S, Lelong N, Khoshnood B, Warszawski J, Blanche S; French National Agency for Research on AIDS and Viral Hepatitis French Perinatal Cohort/Protease Inhibitor Monotherapy Evaluation Trial..

Clin Infect Dis. 2015 Jul 15;61(2):270-80. doi: 10.1093/cid/civ260.


Dolutegravir in HIV-2-Infected Patients With Resistant Virus to First-line Integrase Inhibitors From the French Named Patient Program.

Descamps D, Peytavin G, Visseaux B, Tubiana R, Damond F, Campa P, Charpentier C, Khuong-Josses MA, Duvivier C, Karmochkine M, Lukiana T, Matheron S.

Clin Infect Dis. 2015 May 15;60(10):1521-7. doi: 10.1093/cid/civ124.


Pharmacokinetics, safety and efficacy of ritonavir-boosted atazanavir (300/100 mg once daily) in HIV-1-infected pregnant women.

Lê MP, Mandelbrot L, Descamps D, Soulié C, Ichou H, Bourgeois-Moine A, Damond F, Lariven S, Valantin MA, Landman R, Faucher P, Tubiana R, Duro D, Meier F, Legac S, Bourse P, Mortier E, Dommergues M, Calvez V, Matheron S, Peytavin G.

Antivir Ther. 2015;20(5):507-13. doi: 10.3851/IMP2936.


Mutation V111I in HIV-2 reverse transcriptase increases the fitness of the nucleoside analogue-resistant K65R and Q151M viruses.

Deuzing IP, Charpentier C, Wright DW, Matheron S, Paton J, Frentz D, van de Vijver DA, Coveney PV, Descamps D; ANRS CO5 HIV-2 Cohort., Boucher CA, Beerens N.

J Virol. 2015 Jan;89(1):833-43. doi: 10.1128/JVI.02259-14.


Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation.

Yin DE, Warshaw MG, Miller WC, Castro H, Fiscus SA, Harper LM, Harrison LJ, Klein NJ, Lewis J, Melvin AJ, Tudor-Williams G, McKinney RE Jr; PENPACT-1 (PENTA 9/PACTG 390) Study Team..

Pediatrics. 2014 Oct;134(4):e1104-16. doi: 10.1542/peds.2014-0527.


HIV-2 X4 tropism is associated with lower CD4+ cell count in treatment-experienced patients.

Visseaux B, Charpentier C, Rouard C, Fagard C, Glohi D, Tubiana R, Damond F, Brun-Vézinet F, Matheron S, Descamps D; French HIV-2 ANRS Cohort CO5..

AIDS. 2014 Sep 10;28(14):2160-2. doi: 10.1097/QAD.0000000000000373.


New sensitive one-step real-time duplex PCR method for group A and B HIV-2 RNA load.

Avettand-Fenoel V, Damond F, Gueudin M, Matheron S, Mélard A, Collin G, Descamps D, Chaix ML, Rouzioux C, Plantier JC; ANRS-CO5 HIV-2 and the ANRS-AC11 Quantification Working Group..

J Clin Microbiol. 2014 Aug;52(8):3017-22. doi: 10.1128/JCM.00724-14.

Items per page

Supplemental Content

Loading ...
Support Center